Chronic kidney disease stage | MDRD estimate | Proteinuria
Item
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min and and 0.5 g/day<proteinuria<3g/day.
boolean
C2074731 (UMLS CUI [1,1])
C3839656 (UMLS CUI [1,2])
C0033687 (UMLS CUI [1,3])
Age
Item
2. age between 18 and 75 years old.
boolean
C0001779 (UMLS CUI [1])
Recent hospitalization for cardiac morbidity absent | Recent hospitalization for infection related morbidity absent
Item
3. patients without hospitalization for cardiac or infection related morbidity over the previous 2 months(due to the potential confounding effects on baseline study variables).
boolean
C0019993 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C0019993 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C0332185 (UMLS CUI [2,4])
C0332197 (UMLS CUI [2,5])
Informed consent
Item
4. patients who are able to provide consent to participate in the study.-
boolean
C0021430 (UMLS CUI [1])
Significant mental illness | Pregnancy | Other vulnerable populations
Item
1. patients will significant mental illness, pregnant women, and other vulnerable populations.
boolean
C0004936 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2])
C0949366 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
Active hepatic disease | ALT mesurement increased
Item
2. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
boolean
C0023895 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0201836 (UMLS CUI [2,1])
C0442805 (UMLS CUI [2,2])
History of congestive heart failure | NYHA classification
Item
3. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
boolean
C0262926 (UMLS CUI [1,1])
C0018802 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,4])
Patients for whom living donor renal transplantation is already scheduled or in the process of being evaluate
Item
4. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
boolean
C0022671 (UMLS CUI [1,1])
C0348050 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0022671 (UMLS CUI [2,1])
C0348050 (UMLS CUI [2,2])
C0220825 (UMLS CUI [2,3])
Severe comorbidities
Item
5. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Receiving immune modulating medications due to active inflammation
Item
6. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
boolean
C0013227 (UMLS CUI [1,1])
C0678889 (UMLS CUI [1,2])
C0021368 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,4])
C0678226 (UMLS CUI [1,5])
Adrenal Cortex Hormones
Item
7. patients who are on corticosteroid therapy.
boolean
C0001617 (UMLS CUI [1])
Informed consent absent
Item
8. patients who do not consent to participate in the study.
boolean
C0021430 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])